PATENT FIGHTS SLOW TOMATO ROLLOUTS

The availability of genetically engineered tomatoes nationwide could be in question, since the three bioengineering firms that have Food and Drug Administration clearance to market those tomatoes are all involved in patent-infringement disputes.Last month, Monsanto Co., St. Louis, filed a complaint in U.S. District Court in Delaware that alleges DNA Plant Technology, Oakland, Calif., infringed upon

The availability of genetically engineered tomatoes nationwide could be in question, since the three bioengineering firms that have Food and Drug Administration clearance to market those tomatoes are all involved in patent-infringement disputes.

Register to view the full article